Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Marts 2022

Biotek-snakken — Marts 2022

Planlagt Fastgjort Låst Flyttet Biotek-snakken
87 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • F Offline
    F Offline
    Fandel
    wrote on sidst redigeret af
    #13

    Godmorgen...

    1 Reply Last reply
    0
    • F Offline
      F Offline
      Fandel
      wrote on sidst redigeret af
      #14

      Godmorgen...

      1 Reply Last reply
      0
      • S Offline
        S Offline
        Sukkeralf
        wrote on sidst redigeret af
        #15

        The never ending story:

        1 Reply Last reply
        0
        • S Offline
          S Offline
          Sukkeralf
          wrote on sidst redigeret af
          #16

          Link Preview Image
          Bioporto vil hente stort millionbeløb i aktieemission

          Eksisterende aktionærer får fortegningsret, når Bioporto skal hente op mod 100 mio. kr. i en aktieemmission.

          favicon

          (medwatch.dk)

          1 Reply Last reply
          0
          • P Offline
            P Offline
            ProinvestorNEWS
            wrote on sidst redigeret af
            #17

            Bioporto venter driftsunderskud på 95-100 mio. kr. i 2022 - NY2 https://proinvestor.com/investornyt/791618/bioporto-venter-driftsunderskud-pa-95-100-mio-kr-i-2022-ny2

            1 Reply Last reply
            0
            • Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktør
              wrote on sidst redigeret af
              #18

              Evaxion Biotech Completes Recruitment for Phase 1/2a Clinical Trial for EVX-02 https://evaxion-biotech.com/news-and-events/press-releases/news-details/2022/Evaxion-Biotech-Completes-Recruitment-for-Phase-12a-Clinical-Trial-for-EVX-02/default.aspx

              1 Reply Last reply
              0
              • F Offline
                F Offline
                Fandel
                wrote on sidst redigeret af
                #19

                Godmorgen...

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  ProinvestorNEWS
                  wrote on sidst redigeret af
                  #20

                  Bavarian/Jefferies: Sænker kursmål til 290 kr. fra 415 kr. https://proinvestor.com/investornyt/792077/bavarian-jefferies-saenker-kursmal-til-290-kr-fra-415-kr

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    ProinvestorNEWS
                    wrote on sidst redigeret af
                    #21

                    HK Privat stævner Novozymes for at underbetale kvinder https://nyheder.tv2.dk/samfund/2022-03-08-hk-privat-staevner-novozymes-for-at-underbetale-kvinder?fbclid=IwAR1J-0SjvFOSFcV2xSbgCXTEY6Ym3KOGa-iae_aaL7eMcZZP5dr-XjwRgns

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #22

                      Genmab Announces U.S. Food and Drug Administration Granted Orphan-Drug Designation to Epcoritamab (DuoBody®-CD3xCD20) in Follic https://proinvestor.com/investornyt/792186/genmab-announces-us-food-and-drug-administration-granted-orphan-drug-designation-to-epcoritamab-duobody-cd3xcd20-in-follic

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        ProinvestorNEWS
                        wrote on sidst redigeret af
                        #23

                        Genmab får eftertragtet status til lægemiddelhåb - NY https://proinvestor.com/investornyt/792211/genmab-far-eftertragtet-status-til-laegemiddelhab-ny

                        1 Reply Last reply
                        0
                        • F Offline
                          F Offline
                          Fandel
                          wrote on sidst redigeret af
                          #24

                          Godmorgen...

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            ProinvestorNEWS
                            wrote on sidst redigeret af
                            #25

                            Sanofi og Sobi når vigtige mål i fase 3-studie af blødermidel https://proinvestor.com/investornyt/792726/sanofi-og-sobi-nar-vigtige-mal-i-fase-3-studie-af-blodermidel

                            1 Reply Last reply
                            0
                            • F Offline
                              F Offline
                              Fandel
                              wrote on sidst redigeret af
                              #26

                              Analysguiden publishes research report setting new price target of SEK 39 with an optimistic fair value of at least SEK 80

                              1 Reply Last reply
                              0
                              • F Offline
                                F Offline
                                Fandel
                                wrote on sidst redigeret af
                                #27

                                Det er Expres2ion der er tale om...

                                1 Reply Last reply
                                0
                                • A Offline
                                  A Offline
                                  Aps_invest
                                  wrote on sidst redigeret af
                                  #28

                                  XBrane analyse… https://s3-eu-west-1.amazonaws.com/rdey-cms-prod/app/uploads/2022/03/xbrane-2022-03-09.pdf

                                  1 Reply Last reply
                                  0
                                  • M Offline
                                    M Offline
                                    Mcjean
                                    wrote on sidst redigeret af
                                    #29

                                    Ser ud til Pzifer har søgt en Form 25 og pilles af børsen, men mangler at få det bekræftet https://www.sec.gov/Archives/edgar/data/78003/000087666122000258/xslF25X02/primary_doc.xml

                                    1 Reply Last reply
                                    0
                                    • M Offline
                                      M Offline
                                      Mcjean
                                      wrote on sidst redigeret af
                                      #30

                                      Er højest sandsynlig en and, men man ved aldrig i disse tider.

                                      1 Reply Last reply
                                      0
                                      • M Offline
                                        M Offline
                                        Mcjean
                                        wrote on sidst redigeret af
                                        #31

                                        Tror det er Arena de delister, hvilket vel ikke er så underligt.

                                        1 Reply Last reply
                                        0
                                        • F Offline
                                          F Offline
                                          Fandel
                                          wrote on sidst redigeret af
                                          #32

                                          Godmorgen...

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper